Hironao Hozumi

46PUBLICATIONS
47CO-AUTHORS
Disease surveillanceEpidemiological methodsCancer cell biologyMedical mycologyPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (46)

|Oct 12, 2026
Increased Risk of Thyrotoxicosis After COVID-19 in Adolescents and Young Adults During the Omicron-Predominant Period: A Nationwide Matched Study.

|Feb 19, 2026
Clinical Characteristics and Prevalence of Apical Scarring at Chest CT in a Healthy Population.

Atsuki Fukada, Hironao Hozumi, Taiki Fukuda

|Feb 10, 2026
Cold inducible RNA binding protein promotes fibroblast activation and its inhibition represents a potential therapeutic target in pulmonary fibrosis.

Yasutaka Mochizuka, Hironao Hozumi, Hirofumi Watanabe

|Jan 23, 2026
Serum interferon-λ3 as a short-term biomarker of disease control in anti-MDA5-positive dermatomyositis-associated ILD.

Yoshihiro Kitahara, Tomoyuki Fujisawa, Atsuki Fukada

|Oct 15, 2025
Survival benefit of immune checkpoint inhibitors for non-small cell lung cancer patients with interstitial lung diseases: a nationwide population-based study.

Masato Karayama, Koichi Miyashita, Yusuke Inoue

|Aug 14, 2025
PAI-1 Inhibitor TM5441 Attenuates Emphysema and Airway Inflammation in a Murine Model of Chronic Obstructive Pulmonary Disease.

Kyohei Oishi, Hideki Yasui, Yusuke Inoue

Pageof 8

Frequent Collaborators

32 joint publications

Tomoyuki Fujisawa

28 joint publications

Yuzo Suzuki

19 joint publications

Noriyuki Enomoto

18 joint publications

Masato Karayama